Gilbert Besong

This inventor holds 22 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Herbicide Resistance. Top assignees: Astex Therapeutics Limited, Basf Se Corporation, Novartis Ag. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilbert Besong. Retrieved from https://idiyas.com/inventor/gilbert-besong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 7)

% Patents Active = 81.8

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 10.2

ph-index = 10

Forward Citations = 254(Granted Patents)

Location History:

Cambridge, GB (2011 - 2016)
Bad Duerkheim, DE (2014 - 2022)

Company Filing History:

17 out of 126

Astex Therapeutics Limited

where one patent can have more than one assignee

Years Active: 2011-2022

Loading Chart...

Areas of Expertise:

Herbicide-Resistant

Hydroxyphenylpyruvate

Dioxygenases

Pyrazolyl

Quinoxaline

Kinase Inhibitors

Substituted Pyridines

Bicyclic Heterocycles

Pharmaceutical Compounds

Protein Tyrosine Kinase

FGFR Inhibitors

Pyrrolopyrimidine

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11248234 - Herbicide-resistant hydroxyphenylpyruvate dioxygenases (2022-02-15),

2. 10619138 - Herbicide-resistant hydroxyphenylpyruvate dioxygenases (2020-04-14),

3. 10519137 - Pyrazolyl quinoxaline kinase inhibitors (2019-12-31),

4. 10167297 - Substituted pyridine compounds having herbicidal activity (2019-01-01),

5. 10052320 - Substituted quinoxalines as FGFR kinase inhibitors (2018-08-21),

6. 10023590 - Substituted pyridine compounds having herbicidal activity (2018-07-17),

7. 9856236 - Substituted quinoxalines as FGFR kinase inhibitors (2018-01-02),

8. 9850228 - Pyrazolyl quinoxaline kinase inhibitors (2017-12-26),

9. 9464071 - Pyrazolyl quinoxaline kinase inhibitors (2016-10-11),

10. 9416136 - Pyrrolopyrimidine compounds and their uses (2016-08-16),

11. 9303029 - Substituted quinoxalines as FGFR kinase inhibitors (2016-04-05),

12. 9290478 - Substituted quinoxalines as FGFR kinase inhibitors (2016-03-22),

13. 9145354 - Pharmaceutical compounds (2015-09-29),

14. 8895745 - Bicyclic heterocyclic compounds as FGFR inhibitors (2014-11-25),

15. 8895601 - Pyrazolyl quinoxaline kinase inhibitors (2014-11-25),

Sure, here is the article about inventor Gilbert Besong:

Title: Gilbert Besong: A Pioneer in Innovation

Introduction:

Gilbert Besong, a man of remarkable vision and dedication, has left an indelible mark on the world of inventions. His relentless pursuit of innovation has made him a true pioneer in the field, inspiring generations of inventors to push the boundaries of what is possible.

Latest Patents:

Gilbert Besong has an impressive track record with 22 patents to his name. His latest patents include groundbreaking work in the development of herbicide-resistant hydroxyphenylpyruvate dioxygenases. These patents detail methods for producing transgenic plants with increased herbicide tolerance or resistance, revolutionizing agricultural practices.

Career Highlights:

Besong's career boasts a rich tapestry of contributions to several renowned companies, including Astex Therapeutics Limited and BASF SE Corporation. Within these organizations, his innovative spirit shone brightly, leading to advancements that have had a lasting impact on the industry.

Collaborations:

Throughout his career, Gilbert Besong has collaborated with esteemed professionals in the field, including coworkers Christopher William Murray and Valerio Berdini. Together, they have fueled each other's creativity, driving forward groundbreaking innovations that have reshaped the landscape of inventions.

Conclusion:

In conclusion, Gilbert Besong's legacy stands as a testament to the power of relentless innovation and a steadfast commitment to progress. His pioneering work continues to inspire future generations to think boldly, push boundaries, and create solutions that drive meaningful change in the world.

Profile summary based on public USPTO records.